WillItSurvive

Neusoft Corporation

Chinese IT services and outsourcing firm doing government, telecom, energy, and medical device software.

Losing its protection
Assessed 21 July 2026 · Evidence as of 21 July 2026
The structural protection is eroding.
On the recordSince 21 July 2026 · Checkable from Aug 28, 2026 · Every call on the record Checkpoint: Q2 2026 earnings report
The call

Revenue keeps growing but profit keeps shrinking, a sign Neusoft is spending hard to defend a services business that AI agents are starting to automate.

Neusoft does software development, app testing, and back-office work for banks, hospitals, and power companies in China. The problem is clear: new AI tools like Yonyou YonClaw and Kingsoft WPS AI can now do much of that work automatically, and Neusoft is spending heavily to compete rather than making profit. The company's medical devices business and partnerships with car makers are smaller pieces that could matter more, but only if those grow fast enough to offset the squeeze in its main services business.

Why
01
AI pressure: Yonyou YonClaw, Kingsoft WPS AI 4.0, SenseTime Office Raccoon. Digital employee agents already automate app dev, testing, and BPO work that makes up Neusoft's core service revenue. Could AI do the core job? Yes, likely.
02
Bigger players: Yonyou Network Technology and Huawei. Yonyou's cleared AI agent platform and Huawei's cockpit and government IT push both target the same accounts Neusoft depends on. Could a giant copy it? Yes, easily.
03
What protects it. Long-standing government, telecom, and energy relationships plus a hardware-tied medical device affiliate that AI can't easily replicate.
What would change this call
Neusoft's Q2 2026 earnings (due Aug 28, 2026) show net loss or profit. Whether AI R&D spend is starting to pay back or is still eroding margins.
Neusoft Medical's Hong Kong IPO completes or stalls further. Whether the profitable medical-device affiliate can crystallize value to offset services weakness.
Yonyou or Huawei publicly wins Chinese government, telecom or energy IT contracts previously held by Neusoft. Whether Neusoft's incumbent client base is actually eroding, not just under pressure.
Key numbers
  • FY2025 revenue RMB 12.04B, up 4.14% (2025-12-31)
  • Q1 2026 net loss of RMB 147.5M (2026-03-31)
  • H1 2025 net profit down 42.75% YoY (2025-06-30)
Named risks
  • Core IT services and BPO workflows are directly targeted by AI-native agents from Yonyou, Kingsoft and SenseTime. Severity: high
  • Net losses widening (Q1 2026: -RMB147.5m) while funding AI R&D with no disclosed profit inflection yet. Severity: high
  • Neusoft Medical's Hong Kong IPO has stalled repeatedly since 2022, leaving affiliate value unrealized. Severity: medium
  • Conflicting headcount data (18,021 to 22,756) makes workforce trend hard to verify. Severity: low
  • Automotive cockpit AI partnerships (Cerence, AISpeech) remain at MOU stage without disclosed revenue. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Yonyou Network Technologylosing toYonyou's YonClaw AI agent cleared China's national security assessment for enterprise AI tools by 2026-07-21
HuaweicontestingHuawei competes directly in government IT and automotive cockpit software, Neusoft's core incumbency areas
Kingsoftlosing toKingsoft's WPS AI 4.0 automates office/BPO workflows overlapping Neusoft's traditional IT services, per 2026-07-21 report
Cerence AIcontestingPartnered via MOU on automotive cockpit voice AI signed 2026-01-22, while also a rival platform provider
Philips, GE HealthCare, Siemens HealthineerscontestingNeusoft Medical launched NeuViz P10 photon-counting CT in December 2025 to compete in premium imaging
Questions people ask
Is Neusoft Corporation profitable in 2026?
No, Neusoft posted a net loss of RMB 147.5 million in Q1 2026, versus a RMB 12.1 million loss a year earlier, even as Q1 revenue rose 2.46% YoY to RMB 1.90 billion, per Quartr data published 2026-06-18.
Could AI replace Neusoft's IT services business?
Neusoft's core app-development, testing and BPO segments are exactly what China's AI-native 'digital employee' agents like Yonyou YonClaw and Kingsoft WPS AI 4.0 are automating, per NDTV Profit reporting dated 2026-07-21, though its medical-hardware and government IT ties are less exposed.
Who is Neusoft Corporation's biggest competitor?
In Chinese enterprise software, Yonyou Network Technology (UFIDA) is the closest domestic peer, now pursuing its own AI agent platform and a Hong Kong IPO as of 2026-07-21; in medical imaging Neusoft Medical competes with Philips, GE HealthCare and Siemens Healthineers.
Who owns Neusoft Corporation?
Neusoft has no controlling shareholder; the largest holder is Dalian Neusoft Holding Co. at about 14.56% as of Q1 2026, followed by Alps Alpine (~8.28%) and SAP SE (~1.36%), per Neusoft's own shareholder disclosure dated 2026-04-29.
Is Neusoft Medical Systems going public?
Neusoft Medical Systems, spun off in 2016 with Neusoft Corp retaining roughly a 30% stake, has repeatedly attempted a Hong Kong IPO since at least 2022, but no completed listing has been confirmed as of the latest 2022-09-13 reporting.
How many employees does Neusoft Corporation have?
Estimates vary: Revelio Labs counts about 20,231 employees worldwide as of December 2025 (roughly flat YoY), while stockanalysis.com cites a company-reported 22,756 as of mid-2025; WSJ lists 18,021 for FY2024, reflecting differing methodologies.
Timeline
  • 2026-07-16Neusoft named to KPMG's Chinese Rehabilitation and Elderly Care 50 List
  • 2026-04-26Launched NAGIC.AI Cockpit Software Platform and AISpeech mobility MoC at Auto China 2026
  • 2026-04-09Showcased AI robotics and health-monitoring products at Japan DX Week Spring 2026
  • 2026-03-31Q1 2026 revenue RMB 1.90 billion, net loss RMB 147.5 million
  • 2026-01-22Signed MOU with Cerence AI for LLM-based automotive cockpit voice AI
  • 2025-12-31FY2025 revenue reached approximately RMB 12.04 billion, up 4.14% YoY
  • 2025-12-02Neusoft Medical launched NeuViz P10, claimed first 8cm wide-coverage photon-counting CT
  • 2025-09-30Nine-month 2025 revenue RMB 7.49 billion, up 8.72% YoY
  • 2025-06-30H1 2025 revenue RMB 4.69 billion, up 9.08% YoY, net profit down 42.75% YoY
  • 2024-12-31FY2024 revenue RMB 11.53 to 11.56 billion, up about 9.6% YoY
Revision history
21 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources